[1] Sarnak MJ.Cardiovascular complications in chronic kidney disease[J]. Am J kidney Dis,2003, 41:11-17. [2] Attar A, Sayadi M. Effect of chronic kidney disease on cardiovascular events: an epidemiological aspect from sprint trial[J]. Iran J Kidney Dis, 2019, 13:328-336. [3] Eastwood SV, Chaturvedi N, Sattar N, et al. Impact of kidney function on cardiovascular risk and mortality: a comparison of south asian and european cohorts[J]. Am J Nephrol, 2019, 30:1-9. [4] Chala G, Sisay T, Teshome Y. Chronic kidney disease and associated risk factors among cardiovascular patients[J]. Int J Nephrol Renovasc Dis, 2019, 12:205-211. [5] Hruska KA. Vascular smooth muscle cells in the pathogenesis of vascular calcification[J]. Circ Res, 2009, 104:710-711. [6] Ronco C, McCullough P, Anker SD, et al. Cardiorenal syndromes: report from the consensus conference of the acute dialysis quality initiative[J]. Eur Heart J, 2010, 31:703-711. [7] Kielstein JT, Bode-Boger SM, Klein G, et al. Endo-genous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure[J]. Eur J Clin Invest, 2010, 33:370-375. [8] Jia SJ, Niu PP, Cong JZ, et al. TLR4 signaling: a potential therapeutic target in ischemic coronary artery disease[J]. Int Immunopharmacol, 2014, 23: 54-59. [9] 徐晓嫦,朱晔,张慧涛, 等. Notch 通路在大鼠肾脏缺血再灌注损伤TLR4介导的炎症反应中的作用[J]. 中国病理生理杂志,2016,32:485-491. [10] 陈昱, 陈志坚, 廖玉华, 等. 急性心肌梗死大鼠肿瘤坏死因子α表达与室性心律失常的关系[J]. 中华急诊医学杂志, 2010, 19: 712-716. [11] 韩慧儒. 急性心肌梗死患者溶栓治疗前后血清肿瘤坏死因子的变化及意义[J]. 中国老年学杂志, 2015,35: 3126-3127. |